CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 1 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $80,000 | -81.2% | 44,601 | -12.0% | 0.04% | -79.1% |
Q2 2020 | $425,000 | +13.6% | 50,694 | -28.9% | 0.20% | +30.5% |
Q1 2020 | $374,000 | -16.1% | 71,343 | -12.7% | 0.15% | +111.0% |
Q4 2019 | $446,000 | +147.8% | 81,751 | +121.7% | 0.07% | +102.8% |
Q3 2019 | $180,000 | -33.3% | 36,881 | -5.3% | 0.04% | -36.8% |
Q2 2019 | $270,000 | -4.3% | 38,935 | -4.2% | 0.06% | -90.5% |
Q1 2019 | $282,000 | +4.8% | 40,628 | -12.0% | 0.60% | +1204.3% |
Q4 2018 | $269,000 | -54.0% | 46,147 | -40.4% | 0.05% | -23.3% |
Q3 2018 | $585,000 | -12.8% | 77,428 | -41.7% | 0.06% | -89.9% |
Q2 2018 | $671,000 | +7.4% | 132,890 | +29.7% | 0.59% | +9.4% |
Q1 2018 | $625,000 | +85.5% | 102,493 | +116.1% | 0.54% | +28.1% |
Q4 2017 | $337,000 | -15.8% | 47,426 | -15.2% | 0.42% | +683.3% |
Q3 2017 | $400,000 | +25.0% | 55,909 | +10.1% | 0.05% | +12.5% |
Q2 2017 | $320,000 | +19.4% | 50,795 | +56.1% | 0.05% | 0.0% |
Q1 2017 | $268,000 | +7.6% | 32,545 | +10.6% | 0.05% | -35.1% |
Q4 2016 | $249,000 | – | 29,425 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $27,550,000 | 20.34% |
AdvisorShares Investments LLC | 380,750 | $2,079,000 | 1.29% |
ETF MANAGERS GROUP, LLC | 5,779,642 | $31,557,000 | 1.10% |
DAFNA Capital Management LLC | 297,300 | $1,623,000 | 0.56% |
GENERAL AMERICAN INVESTORS CO INC | 632,400 | $3,453,000 | 0.32% |
Aries Wealth Management | 27,900 | $160,000 | 0.10% |
Virtus ETF Advisers LLC | 81,751 | $446,000 | 0.07% |
Omnia Family Wealth, LLC | 21,726 | $119,000 | 0.06% |
HighVista Strategies LLC | 12,200 | $67,000 | 0.05% |
WOODSTOCK CORP | 57,213 | $312,000 | 0.05% |